Ajanta Pharma USA Inc recalls Aripiprazole Tablets USP
- Recalling company
- Ajanta Pharma USA Inc
- Product
- Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.
- Reason
- Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- May 27, 2026
- Reported
- Jun 24, 2026
- Distribution
- U.S. Nationwide
- Status
- Ongoing
- Quantity
- 6,143 bottles
- Lot / codes
- Lot: PA00805, expires: 01/31/2029
- Company location
- Bridgewater, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0594-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0594-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.